University of California San Francisco
Give to UCSF
A chemical that could potentially be used in eye drops to reverse cataracts has been identified by a team of scientists from UCSF, the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
A research team led by UCSF scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice.
UCSF Sandler Fellow Joseph Bondy-Denomy studies the native roles of CRISPR and anti-CRISPR proteins in bacteria and phages.
UCSF ranks among the top five schools in the world in seven subject areas, according to the 2015 U.S. News & World Report's 2016 Best Global Universities rankings.
The National Institutes of Health (NIH) has awarded seven grants to UCSF scientists to pursue innovative approaches to major contemporary challenges in biomedical research.
A virus is nature’s efficient little killer. They’re really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
UCSF researchers have engineered a molecular “on switch” that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer.
Zev Gartner is working to building a fully functioning 3-D human breast tissue that will allow him to test potential cancer therapies, an innovation that's earned him a spot among Popular Science's "Brilliant 10" this year.
A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN), a consortium comprising research groups from UCSF, the University of Chicago and the University of Toronto, will support the development of next-generation, antibody-based cancer therapies.
In a perspective published by the New England Journal of Medicine, UCSF's Elizabeth Watkins shares a historical perspective of pharmaceutical advertising and proposes a new approach for educating consumers.
Researchers at UCSF are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers.
Voriconazole, a prescription drug commonly used to treat fungal infections in lung transplant recipients, significantly increases the risk for skin cancer and even death, according to a new study by UCSF researchers.
UCSF researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
UCSF ranks among the world’s leading research universities for the ninth year in a row, according to the 2015 Academic Ranking of World Universities.
The Perry Initiative, a nonprofit founded in 2009 by Lisa Lattanza and Jenni Buckley, aims to tackle gender imbalance in engineering and orthopaedics by providing bioengineering workshops for high school students.
